gms | German Medical Science

65th Annual Meeting of the German Association for Medical Informatics, Biometry and Epidemiology (GMDS), Meeting of the Central European Network (CEN: German Region, Austro-Swiss Region and Polish Region) of the International Biometric Society (IBS)

06.09. - 09.09.2020, Berlin (online conference)

Effective visual reporting for credible, data-driven decision making

Meeting Abstract

Search Medline for

  • Mark Baillie - Novartis, Basel, Switzerland

Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie. 65th Annual Meeting of the German Association for Medical Informatics, Biometry and Epidemiology (GMDS), Meeting of the Central European Network (CEN: German Region, Austro-Swiss Region and Polish Region) of the International Biometric Society (IBS). Berlin, 06.-09.09.2020. Düsseldorf: German Medical Science GMS Publishing House; 2021. DocAbstr. 174

doi: 10.3205/20gmds063, urn:nbn:de:0183-20gmds0631

Published: February 26, 2021

© 2021 Baillie.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Effective visual communication is a core task for all scientists including statisticians, epidemiologists, machine learning experts, bioinformaticians, etc. By using the right graphical principles, we can better understand data, highlight core insights and influence decisions toward appropriate actions. Without it, we can fool ourselves and others and pave the way to wrong conclusions and actions. While numerous solutions exist to analyze data, these often require many manual steps to convert them into visually convincing and meaningful reports. How do we put this in practice in an accurate, transparent and reproducible way? This talk will introduce an open collaborative effort, currently undertaken by Roche and Novartis, to develop solutions for effective visual communication with a focus on reporting medical and clinical data. The aim of the collaboration is to develop a user-friendly, fit for purpose, open source package to simplify the use of good graphical principles for effective visual communication of typical analyses of interventional and observational data encountered in clinical drug development.

The authors declare that an ethics committee vote is not required.